systemic lupus erythematosus (SLE)
Conditions
Interventions
the Controled Group:basic oral therapy
the Treated Group:basic oral therapy + Autologous blood transfusion with oxygen-ozone + acupoint injection with oxygen-ozone on ST 36
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. SLE patients with a SLEDAI score of 5-14; 2. Patients with age between 18-65 years old; 3. Patienbs agree to sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients do not meet the diagnosis of SLE; 2. Patients fail to sign the informed consent; 3. Patients with mean pulmonary arterial pressure>50mgHg, or non controllable infection, or organ failure; 4. Pregnant or lactating women; 5. Patients who are participating in another clinical trial; 6. Researchers of this study; 7. Unwilling to comply with treatment or assessment regimen; 8. Unable to comply with treatment or assessment regimen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SLEDAI score; | — |
Secondary
| Measure | Time frame |
|---|---|
| autoimmune antibody tests;ESR;CRP;SF-36; | — |
Countries
China
Contacts
Public ContactLili Pan
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed